← Previous Post: | Next Post:

 

“Harvard medical professionals collected a significant percentage of the speaking fees doled out by pharmaceutical companies in 2009 and the first half of 2010. But recent data shows that many Harvard affiliates ceased making promotional speeches in the second half of 2010 and first quarter of 2011 as tighter University and Medical School regulations have taken effect.”

Pharma loved Harvard because of its big ol’ name.

That has changed, as a Harvard professor who studies the interaction between industry and med school professors notes. “For a long time in medicine, not just at Harvard, but everywhere, there was a culture that said doctors were entitled to industry perks, but that culture is breaking down,” [Eric] Campbell said. “Doctors no longer assume it is their right and duty to accept these perks from industry.”

But hey. One school keeps the perk banner waving — and it’s UD‘s own GW!

“It’s just a rough environment,” said Dr. Lawrence DuBuske, [a Massachusetts] allergy specialist… “The industry wants very little to do with Massachusetts.”

DuBuske, who has been a top speaker for GSK and AstraZeneca about asthma medications, resigned from Brigham and Women’s last year, rather than give up his speaking appearances. Since then, he has landed a job at George Washington University School of Medicine and Medical Center in Washington, D.C.

Margaret Soltan, September 10, 2011 9:19AM
Posted in: conflict of interest

Trackback URL for this post:
https://www.margaretsoltan.com/wp-trackback.php?p=32393

Comment on this Entry

Latest UD posts at IHE

Archives

Categories